Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 407

1.

The relationship between CAG repeat length and clinical progression in Huntington's disease.

Ravina B, Romer M, Constantinescu R, Biglan K, Brocht A, Kieburtz K, Shoulson I, McDermott MP.

Mov Disord. 2008 Jul 15;23(9):1223-7. doi: 10.1002/mds.21988.

PMID:
18512767
2.

The association of CAG repeat length with clinical progression in Huntington disease.

Rosenblatt A, Liang KY, Zhou H, Abbott MH, Gourley LM, Margolis RL, Brandt J, Ross CA.

Neurology. 2006 Apr 11;66(7):1016-20.

PMID:
16606912
3.

[Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].

Vojvodić N, Culjković B, Romac S, Stojković O, Sternić N, Sokić D, Kostić VS.

Srp Arh Celok Lek. 1998 Mar-Apr;126(3-4):77-82. Serbian.

PMID:
9863360
4.

Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.

Ruocco HH, Bonilha L, Li LM, Lopes-Cendes I, Cendes F.

J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):130-5. Epub 2007 Jul 5.

PMID:
17615168
5.

Unified Huntington's disease rating scale: clinical practice and a critical approach.

Klempír J, Klempírova O, Spacková N, Zidovská J, Roth J.

Funct Neurol. 2006 Oct-Dec;21(4):217-21.

PMID:
17367582
6.

Severity of cognitive impairment in juvenile and late-onset Huntington disease.

Gómez-Tortosa E, del Barrio A, García Ruiz PJ, Pernaute RS, Benítez J, Barroso A, Jiménez FJ, García Yébenes J.

Arch Neurol. 1998 Jun;55(6):835-43.

PMID:
9626775
7.

Huntington's disease: clinical correlates of disability and progression.

Mahant N, McCusker EA, Byth K, Graham S; Huntington Study Group.

Neurology. 2003 Oct 28;61(8):1085-92.

PMID:
14581669
8.

Trinucleotide repeat length and progression of illness in Huntington's disease.

Kieburtz K, MacDonald M, Shih C, Feigin A, Steinberg K, Bordwell K, Zimmerman C, Srinidhi J, Sotack J, Gusella J, et al.

J Med Genet. 1994 Nov;31(11):872-4.

9.

CAG mutation effect on rate of progression in Huntington's disease.

Squitieri F, Cannella M, Simonelli M.

Neurol Sci. 2002 Sep;23 Suppl 2:S107-8.

PMID:
12548366
10.

CAG repeat size and clinical presentation in Huntington's disease.

Ashizawa T, Wong LJ, Richards CS, Caskey CT, Jankovic J.

Neurology. 1994 Jun;44(6):1137-43.

PMID:
8208412
11.

Trinucleotide repeat length and clinical progression in Huntington's disease.

Brandt J, Bylsma FW, Gross R, Stine OC, Ranen N, Ross CA.

Neurology. 1996 Feb;46(2):527-31.

PMID:
8614526
12.

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.

Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA, et al.

Nat Genet. 1993 Aug;4(4):398-403.

PMID:
8401589
13.

Bradykinesia in early Huntington's disease.

Sánchez-Pernaute R, Künig G, del Barrio Alba A, de Yébenes JG, Vontobel P, Leenders KL.

Neurology. 2000 Jan 11;54(1):119-25.

PMID:
10636136
14.
15.

Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.

Zappacosta B, Monza D, Meoni C, Austoni L, Soliveri P, Gellera C, Alberti R, Mantero M, Penati G, Caraceni T, Girotti F.

Arch Neurol. 1996 Jun;53(6):493-7.

PMID:
8660149
16.

Trinucleotide repeat length and rate of progression of Huntington's disease.

Illarioshkin SN, Igarashi S, Onodera O, Markova ED, Nikolskaya NN, Tanaka H, Chabrashwili TZ, Insarova NG, Endo K, Ivanova-Smolenskaya IA, et al.

Ann Neurol. 1994 Oct;36(4):630-5.

PMID:
7944295
17.

Complex movement behaviour and progression of Huntington's disease.

Andrich J, Saft C, Ostholt N, Müller T.

Neurosci Lett. 2007 Apr 18;416(3):272-4. Epub 2007 Feb 11.

PMID:
17321683
18.

Assessment of simple movements reflects impairment in Huntington's disease.

Saft C, Andrich J, Meisel NM, Przuntek H, Müller T.

Mov Disord. 2006 Aug;21(8):1208-12.

PMID:
16700032
19.

Relationship between CAG repeat length and late-stage outcomes in Huntington's disease.

Marder K, Sandler S, Lechich A, Klager J, Albert SM.

Neurology. 2002 Nov 26;59(10):1622-4.

PMID:
12451208
20.

Polymorphism of HD and UCHL-1 genes in Huntington's disease.

Xu EH, Tang Y, Li D, Jia JP.

J Clin Neurosci. 2009 Nov;16(11):1473-7. doi: 10.1016/j.jocn.2009.03.027. Epub 2009 Aug 14.

PMID:
19683447
Items per page

Supplemental Content

Write to the Help Desk